GSK reports small rise as Pfizer deal approved

13 May 2019 - Deborah Wilkes

Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 1% at constant exchange rates in the first quarter of 2019. The company's shareholders have just approved the proposed consumer healthcare joint venture with Pfizer.